0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Targeted Metabolomics Market Research Report 2026
Published Date: 2026-01-20
|
Report Code: QYRE-Auto-15P18906
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Targeted Metabolomics Market Research Report 2024
BUY CHAPTERS

Global Targeted Metabolomics Market Research Report 2026

Code: QYRE-Auto-15P18906
Report
2026-01-20
Pages:117
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Targeted Metabolomics Market Size

The global Targeted Metabolomics market was valued at US$ 117 million in 2025 and is anticipated to reach US$ 249 million by 2032, at a CAGR of 11.6% from 2026 to 2032.

Targeted Metabolomics Market

Targeted Metabolomics Market

Targeted metabolomics is a study in which defined metabolites in a sample are identified and quantitatively analyzed. Quantitation and semi-quantitation of defined metabolites are undertaken through the use of internal standard compounds. Targeted metabolomics has an advantage of high specificity and accuracy. Thus, this method has been widely used to analyze and compare multiple targeted metabolites under different physiological states, and is a critical analytical method for discovery of new biomarker in metabolic diseases and study of early diagnosis of diseases.
The North American market for Targeted Metabolomics is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Targeted Metabolomics is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Targeted Metabolomics in Academic and Research Institutions is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Targeted Metabolomics include Creative Dynamics Inc (Creative Proteomics), Metabolon, Allumiqs, CD Genomics, Alfa Chemistry, Novelgene Technologies, MtoZ-Biolabs Inc., BGI Genomics, Metware Biotechnology Inc (Metware), APPLIED PROTEIN TECHNOLOGY, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Targeted Metabolomics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Targeted Metabolomics. The Targeted Metabolomics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Targeted Metabolomics market comprehensively. Regional market sizes by Method, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Targeted Metabolomics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Method, by Application, and by region.
Market Segmentation

Scope of Targeted Metabolomics Market Report

Report Metric Details
Report Name Targeted Metabolomics Market
Accounted market size in 2025 US$ 117 million
Forecasted market size in 2032 US$ 249 million
CAGR 11.6%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Method
  • NMR
  • GC-MS
  • LC-MS
  • HPLC-MS
Segment by Application
  • Academic and Research Institutions
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Creative Dynamics Inc (Creative Proteomics), Metabolon, Allumiqs, CD Genomics, Alfa Chemistry, Novelgene Technologies, MtoZ-Biolabs Inc., BGI Genomics, Metware Biotechnology Inc (Metware), APPLIED PROTEIN TECHNOLOGY, Suzhou PANOMIX Biomedical Tech Co.,Ltd, OBiO Technology ( Shanghai ) Corp.,Ltd., Biotech Pack, Beijing Huayi innovation & BioTechnology Co., Ltd, Abace Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Method, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Targeted Metabolomics companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Method, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Targeted Metabolomics Market growing?

Ans: The Targeted Metabolomics Market witnessing a CAGR of 11.6% during the forecast period 2026-2032.

What is the Targeted Metabolomics Market size in 2032?

Ans: The Targeted Metabolomics Market size in 2032 will be US$ 249 million.

Who are the main players in the Targeted Metabolomics Market report?

Ans: The main players in the Targeted Metabolomics Market are Creative Dynamics Inc (Creative Proteomics), Metabolon, Allumiqs, CD Genomics, Alfa Chemistry, Novelgene Technologies, MtoZ-Biolabs Inc., BGI Genomics, Metware Biotechnology Inc (Metware), APPLIED PROTEIN TECHNOLOGY, Suzhou PANOMIX Biomedical Tech Co.,Ltd, OBiO Technology ( Shanghai ) Corp.,Ltd., Biotech Pack, Beijing Huayi innovation & BioTechnology Co., Ltd, Abace Biotechnology

What are the Application segmentation covered in the Targeted Metabolomics Market report?

Ans: The Applications covered in the Targeted Metabolomics Market report are Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Contract Research Organizations

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Method
1.2.1 Global Targeted Metabolomics Market Size Growth Rate by Method: 2021 vs 2025 vs 2032
1.2.2 NMR
1.2.3 GC-MS
1.2.4 LC-MS
1.2.5 HPLC-MS
1.3 Market by Application
1.3.1 Global Targeted Metabolomics Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Academic and Research Institutions
1.3.3 Pharmaceutical and Biotechnology Companies
1.3.4 Contract Research Organizations
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted Metabolomics Market Perspective (2021–2032)
2.2 Global Targeted Metabolomics Growth Trends by Region
2.2.1 Global Targeted Metabolomics Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Targeted Metabolomics Historic Market Size by Region (2021–2026)
2.2.3 Targeted Metabolomics Forecasted Market Size by Region (2027–2032)
2.3 Targeted Metabolomics Market Dynamics
2.3.1 Targeted Metabolomics Industry Trends
2.3.2 Targeted Metabolomics Market Drivers
2.3.3 Targeted Metabolomics Market Challenges
2.3.4 Targeted Metabolomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted Metabolomics Players by Revenue
3.1.1 Global Top Targeted Metabolomics Players by Revenue (2021–2026)
3.1.2 Global Targeted Metabolomics Revenue Market Share by Players (2021–2026)
3.2 Global Top Targeted Metabolomics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Targeted Metabolomics Revenue
3.4 Global Targeted Metabolomics Market Concentration Ratio
3.4.1 Global Targeted Metabolomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Metabolomics Revenue in 2025
3.5 Global Key Players of Targeted Metabolomics Head Offices and Areas Served
3.6 Global Key Players of Targeted Metabolomics, Products and Applications
3.7 Global Key Players of Targeted Metabolomics, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Targeted Metabolomics Breakdown Data by Method
4.1 Global Targeted Metabolomics Historic Market Size by Method (2021–2026)
4.2 Global Targeted Metabolomics Forecasted Market Size by Method (2027–2032)
5 Targeted Metabolomics Breakdown Data by Application
5.1 Global Targeted Metabolomics Historic Market Size by Application (2021–2026)
5.2 Global Targeted Metabolomics Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Targeted Metabolomics Market Size (2021–2032)
6.2 North America Targeted Metabolomics Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Targeted Metabolomics Market Size by Country (2021–2026)
6.4 North America Targeted Metabolomics Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Targeted Metabolomics Market Size (2021–2032)
7.2 Europe Targeted Metabolomics Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Targeted Metabolomics Market Size by Country (2021–2026)
7.4 Europe Targeted Metabolomics Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Targeted Metabolomics Market Size (2021–2032)
8.2 Asia-Pacific Targeted Metabolomics Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Targeted Metabolomics Market Size by Region (2021–2026)
8.4 Asia-Pacific Targeted Metabolomics Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Targeted Metabolomics Market Size (2021–2032)
9.2 Latin America Targeted Metabolomics Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Targeted Metabolomics Market Size by Country (2021–2026)
9.4 Latin America Targeted Metabolomics Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted Metabolomics Market Size (2021–2032)
10.2 Middle East & Africa Targeted Metabolomics Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Targeted Metabolomics Market Size by Country (2021–2026)
10.4 Middle East & Africa Targeted Metabolomics Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Creative Dynamics Inc (Creative Proteomics)
11.1.1 Creative Dynamics Inc (Creative Proteomics) Company Details
11.1.2 Creative Dynamics Inc (Creative Proteomics) Business Overview
11.1.3 Creative Dynamics Inc (Creative Proteomics) Targeted Metabolomics Introduction
11.1.4 Creative Dynamics Inc (Creative Proteomics) Revenue in Targeted Metabolomics Business (2021–2026)
11.1.5 Creative Dynamics Inc (Creative Proteomics) Recent Development
11.2 Metabolon
11.2.1 Metabolon Company Details
11.2.2 Metabolon Business Overview
11.2.3 Metabolon Targeted Metabolomics Introduction
11.2.4 Metabolon Revenue in Targeted Metabolomics Business (2021–2026)
11.2.5 Metabolon Recent Development
11.3 Allumiqs
11.3.1 Allumiqs Company Details
11.3.2 Allumiqs Business Overview
11.3.3 Allumiqs Targeted Metabolomics Introduction
11.3.4 Allumiqs Revenue in Targeted Metabolomics Business (2021–2026)
11.3.5 Allumiqs Recent Development
11.4 CD Genomics
11.4.1 CD Genomics Company Details
11.4.2 CD Genomics Business Overview
11.4.3 CD Genomics Targeted Metabolomics Introduction
11.4.4 CD Genomics Revenue in Targeted Metabolomics Business (2021–2026)
11.4.5 CD Genomics Recent Development
11.5 Alfa Chemistry
11.5.1 Alfa Chemistry Company Details
11.5.2 Alfa Chemistry Business Overview
11.5.3 Alfa Chemistry Targeted Metabolomics Introduction
11.5.4 Alfa Chemistry Revenue in Targeted Metabolomics Business (2021–2026)
11.5.5 Alfa Chemistry Recent Development
11.6 Novelgene Technologies
11.6.1 Novelgene Technologies Company Details
11.6.2 Novelgene Technologies Business Overview
11.6.3 Novelgene Technologies Targeted Metabolomics Introduction
11.6.4 Novelgene Technologies Revenue in Targeted Metabolomics Business (2021–2026)
11.6.5 Novelgene Technologies Recent Development
11.7 MtoZ-Biolabs Inc.
11.7.1 MtoZ-Biolabs Inc. Company Details
11.7.2 MtoZ-Biolabs Inc. Business Overview
11.7.3 MtoZ-Biolabs Inc. Targeted Metabolomics Introduction
11.7.4 MtoZ-Biolabs Inc. Revenue in Targeted Metabolomics Business (2021–2026)
11.7.5 MtoZ-Biolabs Inc. Recent Development
11.8 BGI Genomics
11.8.1 BGI Genomics Company Details
11.8.2 BGI Genomics Business Overview
11.8.3 BGI Genomics Targeted Metabolomics Introduction
11.8.4 BGI Genomics Revenue in Targeted Metabolomics Business (2021–2026)
11.8.5 BGI Genomics Recent Development
11.9 Metware Biotechnology Inc (Metware)
11.9.1 Metware Biotechnology Inc (Metware) Company Details
11.9.2 Metware Biotechnology Inc (Metware) Business Overview
11.9.3 Metware Biotechnology Inc (Metware) Targeted Metabolomics Introduction
11.9.4 Metware Biotechnology Inc (Metware) Revenue in Targeted Metabolomics Business (2021–2026)
11.9.5 Metware Biotechnology Inc (Metware) Recent Development
11.10 APPLIED PROTEIN TECHNOLOGY
11.10.1 APPLIED PROTEIN TECHNOLOGY Company Details
11.10.2 APPLIED PROTEIN TECHNOLOGY Business Overview
11.10.3 APPLIED PROTEIN TECHNOLOGY Targeted Metabolomics Introduction
11.10.4 APPLIED PROTEIN TECHNOLOGY Revenue in Targeted Metabolomics Business (2021–2026)
11.10.5 APPLIED PROTEIN TECHNOLOGY Recent Development
11.11 Suzhou PANOMIX Biomedical Tech Co.,Ltd
11.11.1 Suzhou PANOMIX Biomedical Tech Co.,Ltd Company Details
11.11.2 Suzhou PANOMIX Biomedical Tech Co.,Ltd Business Overview
11.11.3 Suzhou PANOMIX Biomedical Tech Co.,Ltd Targeted Metabolomics Introduction
11.11.4 Suzhou PANOMIX Biomedical Tech Co.,Ltd Revenue in Targeted Metabolomics Business (2021–2026)
11.11.5 Suzhou PANOMIX Biomedical Tech Co.,Ltd Recent Development
11.12 OBiO Technology ( Shanghai ) Corp.,Ltd.
11.12.1 OBiO Technology ( Shanghai ) Corp.,Ltd. Company Details
11.12.2 OBiO Technology ( Shanghai ) Corp.,Ltd. Business Overview
11.12.3 OBiO Technology ( Shanghai ) Corp.,Ltd. Targeted Metabolomics Introduction
11.12.4 OBiO Technology ( Shanghai ) Corp.,Ltd. Revenue in Targeted Metabolomics Business (2021–2026)
11.12.5 OBiO Technology ( Shanghai ) Corp.,Ltd. Recent Development
11.13 Biotech Pack
11.13.1 Biotech Pack Company Details
11.13.2 Biotech Pack Business Overview
11.13.3 Biotech Pack Targeted Metabolomics Introduction
11.13.4 Biotech Pack Revenue in Targeted Metabolomics Business (2021–2026)
11.13.5 Biotech Pack Recent Development
11.14 Beijing Huayi innovation & BioTechnology Co., Ltd
11.14.1 Beijing Huayi innovation & BioTechnology Co., Ltd Company Details
11.14.2 Beijing Huayi innovation & BioTechnology Co., Ltd Business Overview
11.14.3 Beijing Huayi innovation & BioTechnology Co., Ltd Targeted Metabolomics Introduction
11.14.4 Beijing Huayi innovation & BioTechnology Co., Ltd Revenue in Targeted Metabolomics Business (2021–2026)
11.14.5 Beijing Huayi innovation & BioTechnology Co., Ltd Recent Development
11.15 Abace Biotechnology
11.15.1 Abace Biotechnology Company Details
11.15.2 Abace Biotechnology Business Overview
11.15.3 Abace Biotechnology Targeted Metabolomics Introduction
11.15.4 Abace Biotechnology Revenue in Targeted Metabolomics Business (2021–2026)
11.15.5 Abace Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Targeted Metabolomics Market Size Growth Rate by Method (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of NMR
 Table 3. Key Players of GC-MS
 Table 4. Key Players of LC-MS
 Table 5. Key Players of HPLC-MS
 Table 6. Global Targeted Metabolomics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Targeted Metabolomics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global Targeted Metabolomics Market Size by Region (US$ Million), 2021–2026
 Table 9. Global Targeted Metabolomics Market Share by Region (2021–2026)
 Table 10. Global Targeted Metabolomics Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 11. Global Targeted Metabolomics Market Share by Region (2027–2032)
 Table 12. Targeted Metabolomics Market Trends
 Table 13. Targeted Metabolomics Market Drivers
 Table 14. Targeted Metabolomics Market Challenges
 Table 15. Targeted Metabolomics Market Restraints
 Table 16. Global Targeted Metabolomics Revenue by Players (US$ Million), 2021–2026
 Table 17. Global Targeted Metabolomics Market Share by Players (2021–2026)
 Table 18. Global Top Targeted Metabolomics Players by Tier (Tier 1, Tier 2, and Tier 3), based on Targeted Metabolomics Revenue, 2025
 Table 19. Ranking of Global Top Targeted Metabolomics Companies by Revenue (US$ Million) in 2025
 Table 20. Global 5 Largest Players Market Share by Targeted Metabolomics Revenue (CR5 and HHI), 2021–2026
 Table 21. Global Key Players of Targeted Metabolomics, Headquarters and Area Served
 Table 22. Global Key Players of Targeted Metabolomics, Products and Applications
 Table 23. Global Key Players of Targeted Metabolomics, Date of General Availability (GA)
 Table 24. Mergers and Acquisitions, Expansion Plans
 Table 25. Global Targeted Metabolomics Market Size by Method (US$ Million), 2021–2026
 Table 26. Global Targeted Metabolomics Revenue Market Share by Method (2021–2026)
 Table 27. Global Targeted Metabolomics Forecasted Market Size by Method (US$ Million), 2027–2032
 Table 28. Global Targeted Metabolomics Revenue Market Share by Method (2027–2032)
 Table 29. Global Targeted Metabolomics Market Size by Application (US$ Million), 2021–2026
 Table 30. Global Targeted Metabolomics Revenue Market Share by Application (2021–2026)
 Table 31. Global Targeted Metabolomics Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 32. Global Targeted Metabolomics Revenue Market Share by Application (2027–2032)
 Table 33. North America Targeted Metabolomics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 34. North America Targeted Metabolomics Market Size by Country (US$ Million), 2021–2026
 Table 35. North America Targeted Metabolomics Market Size by Country (US$ Million), 2027–2032
 Table 36. Europe Targeted Metabolomics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 37. Europe Targeted Metabolomics Market Size by Country (US$ Million), 2021–2026
 Table 38. Europe Targeted Metabolomics Market Size by Country (US$ Million), 2027–2032
 Table 39. Asia-Pacific Targeted Metabolomics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 40. Asia-Pacific Targeted Metabolomics Market Size by Region (US$ Million), 2021–2026
 Table 41. Asia-Pacific Targeted Metabolomics Market Size by Region (US$ Million), 2027–2032
 Table 42. Latin America Targeted Metabolomics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 43. Latin America Targeted Metabolomics Market Size by Country (US$ Million), 2021–2026
 Table 44. Latin America Targeted Metabolomics Market Size by Country (US$ Million), 2027–2032
 Table 45. Middle East & Africa Targeted Metabolomics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 46. Middle East & Africa Targeted Metabolomics Market Size by Country (US$ Million), 2021–2026
 Table 47. Middle East & Africa Targeted Metabolomics Market Size by Country (US$ Million), 2027–2032
 Table 48. Creative Dynamics Inc (Creative Proteomics) Company Details
 Table 49. Creative Dynamics Inc (Creative Proteomics) Business Overview
 Table 50. Creative Dynamics Inc (Creative Proteomics) Targeted Metabolomics Product
 Table 51. Creative Dynamics Inc (Creative Proteomics) Revenue in Targeted Metabolomics Business (US$ Million), 2021–2026
 Table 52. Creative Dynamics Inc (Creative Proteomics) Recent Development
 Table 53. Metabolon Company Details
 Table 54. Metabolon Business Overview
 Table 55. Metabolon Targeted Metabolomics Product
 Table 56. Metabolon Revenue in Targeted Metabolomics Business (US$ Million), 2021–2026
 Table 57. Metabolon Recent Development
 Table 58. Allumiqs Company Details
 Table 59. Allumiqs Business Overview
 Table 60. Allumiqs Targeted Metabolomics Product
 Table 61. Allumiqs Revenue in Targeted Metabolomics Business (US$ Million), 2021–2026
 Table 62. Allumiqs Recent Development
 Table 63. CD Genomics Company Details
 Table 64. CD Genomics Business Overview
 Table 65. CD Genomics Targeted Metabolomics Product
 Table 66. CD Genomics Revenue in Targeted Metabolomics Business (US$ Million), 2021–2026
 Table 67. CD Genomics Recent Development
 Table 68. Alfa Chemistry Company Details
 Table 69. Alfa Chemistry Business Overview
 Table 70. Alfa Chemistry Targeted Metabolomics Product
 Table 71. Alfa Chemistry Revenue in Targeted Metabolomics Business (US$ Million), 2021–2026
 Table 72. Alfa Chemistry Recent Development
 Table 73. Novelgene Technologies Company Details
 Table 74. Novelgene Technologies Business Overview
 Table 75. Novelgene Technologies Targeted Metabolomics Product
 Table 76. Novelgene Technologies Revenue in Targeted Metabolomics Business (US$ Million), 2021–2026
 Table 77. Novelgene Technologies Recent Development
 Table 78. MtoZ-Biolabs Inc. Company Details
 Table 79. MtoZ-Biolabs Inc. Business Overview
 Table 80. MtoZ-Biolabs Inc. Targeted Metabolomics Product
 Table 81. MtoZ-Biolabs Inc. Revenue in Targeted Metabolomics Business (US$ Million), 2021–2026
 Table 82. MtoZ-Biolabs Inc. Recent Development
 Table 83. BGI Genomics Company Details
 Table 84. BGI Genomics Business Overview
 Table 85. BGI Genomics Targeted Metabolomics Product
 Table 86. BGI Genomics Revenue in Targeted Metabolomics Business (US$ Million), 2021–2026
 Table 87. BGI Genomics Recent Development
 Table 88. Metware Biotechnology Inc (Metware) Company Details
 Table 89. Metware Biotechnology Inc (Metware) Business Overview
 Table 90. Metware Biotechnology Inc (Metware) Targeted Metabolomics Product
 Table 91. Metware Biotechnology Inc (Metware) Revenue in Targeted Metabolomics Business (US$ Million), 2021–2026
 Table 92. Metware Biotechnology Inc (Metware) Recent Development
 Table 93. APPLIED PROTEIN TECHNOLOGY Company Details
 Table 94. APPLIED PROTEIN TECHNOLOGY Business Overview
 Table 95. APPLIED PROTEIN TECHNOLOGY Targeted Metabolomics Product
 Table 96. APPLIED PROTEIN TECHNOLOGY Revenue in Targeted Metabolomics Business (US$ Million), 2021–2026
 Table 97. APPLIED PROTEIN TECHNOLOGY Recent Development
 Table 98. Suzhou PANOMIX Biomedical Tech Co.,Ltd Company Details
 Table 99. Suzhou PANOMIX Biomedical Tech Co.,Ltd Business Overview
 Table 100. Suzhou PANOMIX Biomedical Tech Co.,Ltd Targeted Metabolomics Product
 Table 101. Suzhou PANOMIX Biomedical Tech Co.,Ltd Revenue in Targeted Metabolomics Business (US$ Million), 2021–2026
 Table 102. Suzhou PANOMIX Biomedical Tech Co.,Ltd Recent Development
 Table 103. OBiO Technology ( Shanghai ) Corp.,Ltd. Company Details
 Table 104. OBiO Technology ( Shanghai ) Corp.,Ltd. Business Overview
 Table 105. OBiO Technology ( Shanghai ) Corp.,Ltd. Targeted Metabolomics Product
 Table 106. OBiO Technology ( Shanghai ) Corp.,Ltd. Revenue in Targeted Metabolomics Business (US$ Million), 2021–2026
 Table 107. OBiO Technology ( Shanghai ) Corp.,Ltd. Recent Development
 Table 108. Biotech Pack Company Details
 Table 109. Biotech Pack Business Overview
 Table 110. Biotech Pack Targeted Metabolomics Product
 Table 111. Biotech Pack Revenue in Targeted Metabolomics Business (US$ Million), 2021–2026
 Table 112. Biotech Pack Recent Development
 Table 113. Beijing Huayi innovation & BioTechnology Co., Ltd Company Details
 Table 114. Beijing Huayi innovation & BioTechnology Co., Ltd Business Overview
 Table 115. Beijing Huayi innovation & BioTechnology Co., Ltd Targeted Metabolomics Product
 Table 116. Beijing Huayi innovation & BioTechnology Co., Ltd Revenue in Targeted Metabolomics Business (US$ Million), 2021–2026
 Table 117. Beijing Huayi innovation & BioTechnology Co., Ltd Recent Development
 Table 118. Abace Biotechnology Company Details
 Table 119. Abace Biotechnology Business Overview
 Table 120. Abace Biotechnology Targeted Metabolomics Product
 Table 121. Abace Biotechnology Revenue in Targeted Metabolomics Business (US$ Million), 2021–2026
 Table 122. Abace Biotechnology Recent Development
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Targeted Metabolomics Picture
 Figure 2. Global Targeted Metabolomics Market Size Comparison by Method (US$ Million), 2021–2032
 Figure 3. Global Targeted Metabolomics Market Share by Method: 2025 vs 2032
 Figure 4. NMR Features
 Figure 5. GC-MS Features
 Figure 6. LC-MS Features
 Figure 7. HPLC-MS Features
 Figure 8. Global Targeted Metabolomics Market Size by Application (US$ Million), 2021–2032
 Figure 9. Global Targeted Metabolomics Market Share by Application: 2025 vs 2032
 Figure 10. Academic and Research Institutions Case Studies
 Figure 11. Pharmaceutical and Biotechnology Companies Case Studies
 Figure 12. Contract Research Organizations Case Studies
 Figure 13. Targeted Metabolomics Report Years Considered
 Figure 14. Global Targeted Metabolomics Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 15. Global Targeted Metabolomics Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global Targeted Metabolomics Market Share by Region: 2025 vs 2032
 Figure 17. Global Targeted Metabolomics Market Share by Players in 2025
 Figure 18. Global Targeted Metabolomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 19. The Top 10 and 5 Players Market Share by Targeted Metabolomics Revenue in 2025
 Figure 20. North America Targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. North America Targeted Metabolomics Market Share by Country (2021–2032)
 Figure 22. United States Targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Canada Targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Europe Targeted Metabolomics Market Share by Country (2021–2032)
 Figure 26. Germany Targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. France Targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. U.K. Targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Italy Targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Russia Targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Ireland Targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Asia-Pacific Targeted Metabolomics Market Share by Region (2021–2032)
 Figure 34. China Targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Japan Targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. South Korea Targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Southeast Asia Targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. India Targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Australia & New Zealand Targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Latin America Targeted Metabolomics Market Share by Country (2021–2032)
 Figure 42. Mexico Targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Brazil Targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Middle East & Africa Targeted Metabolomics Market Share by Country (2021–2032)
 Figure 46. Israel Targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Saudi Arabia Targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. UAE Targeted Metabolomics Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Creative Dynamics Inc (Creative Proteomics) Revenue Growth Rate in Targeted Metabolomics Business (2021–2026)
 Figure 50. Metabolon Revenue Growth Rate in Targeted Metabolomics Business (2021–2026)
 Figure 51. Allumiqs Revenue Growth Rate in Targeted Metabolomics Business (2021–2026)
 Figure 52. CD Genomics Revenue Growth Rate in Targeted Metabolomics Business (2021–2026)
 Figure 53. Alfa Chemistry Revenue Growth Rate in Targeted Metabolomics Business (2021–2026)
 Figure 54. Novelgene Technologies Revenue Growth Rate in Targeted Metabolomics Business (2021–2026)
 Figure 55. MtoZ-Biolabs Inc. Revenue Growth Rate in Targeted Metabolomics Business (2021–2026)
 Figure 56. BGI Genomics Revenue Growth Rate in Targeted Metabolomics Business (2021–2026)
 Figure 57. Metware Biotechnology Inc (Metware) Revenue Growth Rate in Targeted Metabolomics Business (2021–2026)
 Figure 58. APPLIED PROTEIN TECHNOLOGY Revenue Growth Rate in Targeted Metabolomics Business (2021–2026)
 Figure 59. Suzhou PANOMIX Biomedical Tech Co.,Ltd Revenue Growth Rate in Targeted Metabolomics Business (2021–2026)
 Figure 60. OBiO Technology ( Shanghai ) Corp.,Ltd. Revenue Growth Rate in Targeted Metabolomics Business (2021–2026)
 Figure 61. Biotech Pack Revenue Growth Rate in Targeted Metabolomics Business (2021–2026)
 Figure 62. Beijing Huayi innovation & BioTechnology Co., Ltd Revenue Growth Rate in Targeted Metabolomics Business (2021–2026)
 Figure 63. Abace Biotechnology Revenue Growth Rate in Targeted Metabolomics Business (2021–2026)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure